2012, Volume 5, Issue 4, pp 420 – 422

Albuminuria – marker of progressive renal disease

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Correspondence to:Stoian Marilena MD, PhD 5-7 Ion Movila Street, 020475, Bucharest, Romania Telephone: +400722808242; Fax: 0214139917; E-mail: marilenastoian@yahoo.com

Abstract

The presence of albuminuria has long been recognized as an adverse prognostic feature in patients with renal disease: the patients with appreciable albuminuria are much more likely to develop tubulointerstitial scarring and fibrosis and progress to end-stage renal failure. For many years, it was thought that excess albuminuria was simply a marker of a more severe renal disease, which was more likely to progress as a result of this severity rather than as a result of the albuminuria itself. This conviction was strengthened by the general assumption that albumin was a benign or inert molecule serving primarily to exert oncotic pressure and act as a carrier within the circulation. More recently, this view has been challenged with the accumulation of evidence suggesting that albumin is able to influence the function of cells with which it makes contact in the manner of a signalling molecule.

Abbreviations

PTC =Proximal Tubular Epithelial Cells; PDZ acronym combining the first letters of three proteins =post synaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein (zo-1); DNA=Dexoxyribonucleic Acid; PI 3-kinase= Phosphatidylinositol 3-kinase; mRNA= messenger Ribonucleic Acid.

Keywords

About this article

PMC ID: 3539836
PubMed ID: 23346243
DOI: 

Article Publishing Date (print): 15-12-2012
Available Online: 25-12-2012

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues